Size-Dependent In Vivo Transport of Nanoparticles: Implications for Delivery, Targeting, and Clearance

M Xu, Y Qi, G Liu, Y Song, X Jiang, B Du - ACS nano, 2023 - ACS Publications
Understanding the in vivo transport of nanoparticles provides guidelines for designing
nanomedicines with higher efficacy and fewer side effects. Among many factors, the size of …

Tumor abnormality-oriented nanomedicine design

Q Zhou, J Xiang, N Qiu, Y Wang, Y Piao, S Shao… - Chemical …, 2023 - ACS Publications
Anticancer nanomedicines have been proven effective in mitigating the side effects of
chemotherapeutic drugs. However, challenges remain in augmenting their therapeutic …

[HTML][HTML] Current research trends of nanomedicines

Q Liu, J Zou, Z Chen, W He, W Wu - Acta Pharmaceutica Sinica B, 2023 - Elsevier
Owing to the inherent shortcomings of traditional therapeutic drugs in terms of inadequate
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …

Aminopeptidase N‐Responsive Conjugates with Tunable Charge‐Reversal Properties for Highly Efficient Tumor Accumulation and Penetration

R Sun, Y Zhang, X Lin, Y Piao, T Xie… - Angewandte Chemie …, 2023 - Wiley Online Library
Tumor enzyme‐responsive charge‐reversal carriers can induce efficient transcytosis and
lead to efficient tumor infiltration and potent anticancer efficacy. However, the correlations of …

Emerging nanotechnological approaches to regulating tumor vasculature for cancer therapy

C Wang, J Xu, Y Zhang, G Nie - Journal of Controlled Release, 2023 - Elsevier
Abnormal angiogenesis stands for one of the most striking manifestations of malignant
tumor. The pathologically and structurally abnormal tumor vasculature facilitates a hostile …

Design of disintegrable nanoassemblies to release multiple small-sized nanoparticles

D Zhu, H Yan, Y Zhou, LM Nack, J Liu… - Advanced Drug Delivery …, 2023 - Elsevier
The therapeutic and diagnostic effects of nanoparticles highly depend on the efficiency of
their delivery to targeted tissues, such as tumors. The size of nanoparticles, among other …

Screening of Zwitterionic Liposomes with Red Blood Cell‐Hitchhiking and Tumor Cell‐Active Transporting Capability for Efficient Tumor Entrance

Z Zhao, Y Feng, J Xiang, J Liu, Y Piao… - Advanced Functional …, 2023 - Wiley Online Library
The active transport of nanoparticles into the solid tumor through cell transcytosis has shown
great promise in cancer nanomedicine, but it is challenging to develop efficient active …

Role of micelle size in cell transcytosis-based tumor extravasation, infiltration, and treatment efficacy

W Fan, J Xiang, Q Wei, Y Tang, Y Piao, S Shao… - Nano Letters, 2023 - ACS Publications
Transcytosis-based active transport of cancer nanomedicine has shown great promise for
enhancing its tumor extravasation and infiltration and antitumor activity, but how the key …

Transcytosis‐Inducing Multifunctional Albumin Nanomedicines with Deep Penetration Ability for Image‐Guided Solid Tumor Treatment

H Lee, B Park, J Lee, Y Kang, M Han, J Lee, C Kim… - Small, 2023 - Wiley Online Library
Transcytosis is an active transcellular transportation pathway that has garnered interest for
overcoming the limited deep penetration of nanomedicines in solid tumors. In this study, a …

Human solid tumors and clinical relevance of the enhanced permeation and retention effect: a 'golden gate'for nanomedicine in preclinical studies?

P Gawali, A Saraswat, S Bhide, S Gupta, K Patel - Nanomedicine, 2023 - Taylor & Francis
Nanocarriers passively accumulate in solid tumors through irregular wide fenestrations in
neovasculature and increased retention due to poor lymphatic drainage, a phenomenon …